Florida Firm’s Failure To List All Potentially Contaminated Products Leads To Criminal Charges

FDA Office of Criminal Investigations says Raidel Figueroa, former co-owner of Pharmatech in Broward County, is charged with as conspiracy “to manufacture and distribute drugs outside the regulatory oversight of the FDA, to interfere with and obstruct the FDA” in its investigation of Pharmatech’s manufacturing of an OTC monograph constipation treatment.

• Source: Alamy

The discovery in 2016 of bacterial contamination in OTC and other drugs made by Pharmatech LLC has led to the indictment of the Florida firm’s former owner on criminal charges including obstructing a federal investigation by failing to identify all its potentially contaminated products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

Traceability Rule Compliance Extended For Providers Of Herbals, Other Food Ingredients

 

FDA says “extension affords covered entities the additional time necessary to ensure complete coordination across the supply chain in order to fully implement the final rule’s requirements—ultimately providing FDA and consumers with greater transparency and food safety.”

PAGB Launches E-Learning Platform Including CBD ‘Deep Dive’

 
• By 

UK industry association is offering online courses on subjects ranging from UK medicines regulations basics to deep dives on complex topics such as CBD.

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

 

Trade group ready to work hand-in-hand with agency and other supplement industry stakeholders on potential regulatory changes or improvements, says president and CEO Steve Mister. “None of them are upsetting the basic balance of things that DSHEA was attempting to do, but there are things with 30 years that we've identified that need to be kind of fixed.”

Age-Restricting Sales Of Supplements, OTCs Remains Action Item For New Jersey Lawmakers

 

New Jersey Assembly passed bill amended to expand extensively in defining which products, or ingredients, would be subject to a ban on sales to consumers younger than 18.

More from Policy & Regulation

State Actions, Proposals On Food Additive Bans Reflect Interest In Aligning With RFK Jr.’s View

 

Changes established in West Virginia and proposed in numerous other states gained momentum after Trump was elected to his second term as president and nominated Kennedy to head HHS.

Some New Tools, More Old For Supplement Sector Enforcement During Trump’s Second Term

 

Tariffs on imports from China and look at eliminating self-affirmed GRAS pathway introduced under Trump while DoJ Consumer Protection Branch also continues supplement sector priorities enduring across administrations.

Availability Of Counterfeit Supplements Ringing Up Impact On Brand Sales And Consumer Safety

 

Sales of Bioventra’s probiotic put inventory at “a critical low” as “parallel rise in unverified listings on third-party marketplaces prompted concern among” customers. DoJ and food and drug industry attorney say counterfeiting remains a problem in supplement sector.